Search Orphan Drug Designations and Approvals
-
Generic Name: | Soluble complement receptor type 1 |
---|---|
Date Designated: | 03/06/2000 |
Orphan Designation: | Prevention of post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Avant Immunotherapeutics, Inc. 119 Fourth Ave. Needham, Massachusetts 02494 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-